|
🐜
|
Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
20 auth.
A. Hiraoka,
T. Kumada,
K. Michitaka,
H. Toyoda,
T. Tada,
Hidetaro Ueki,
Miho Kaneto,
Toshihiko Aibiki,
Tomonari Okudaira,
Takamasa Kawakami,
...
Tomoe Kawamura,
H. Yamago,
Yoshifumi Suga,
Yuji Miyamoto,
Hideomi Tomida,
Nobuaki Azemoto,
Kenichiro Mori,
H. Miyata,
T. Ninomiya,
H. Kawasaki
|
7 |
2016 |
7
🐜
|
|
🐜
|
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis
25 auth.
A. Hiraoka,
K. Michitaka,
D. Kiguchi,
Hirofumi Izumoto,
Hidetaro Ueki,
Miho Kaneto,
Shogo Kitahata,
Toshihiko Aibiki,
Tomonari Okudaira,
Hideomi Tomida,
Yuji Miyamoto,
H. Yamago,
Yoshifumi Suga,
R. Iwasaki,
Kenichiro Mori,
...
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
Shigeru Kohgami,
M. Hirooka,
Yoshio Tokumoto,
M. Abe,
B. Matsuura,
Y. Hiasa
|
6 |
2017 |
6
🐜
|
|
🐜
|
Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation
16 auth.
A. Hiraoka,
Toshihiko Aibiki,
Tomonari Okudaira,
A. Toshimori,
Tomoe Kawamura,
Hiromasa Nakahara,
Yoshifumi Suga,
Nobuaki Azemoto,
H. Miyata,
Y. Miyamoto,
...
T. Ninomiya,
M. Hirooka,
M. Abe,
B. Matsuura,
Y. Hiasa,
K. Michitaka
|
6 |
2015 |
6
🐜
|
|
🐜
|
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib
23 auth.
A. Hiraoka,
M. Hirooka,
Y. Koizumi,
Hirofumi Izumoto,
Hidetaro Ueki,
Miho Kaneto,
Shogo Kitahata,
Toshihiko Aibiki,
Hideomi Tomida,
Yuji Miyamoto,
...
H. Yamago,
Yoshifumi Suga,
R. Iwasaki,
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
M. Abe,
B. Matsuura,
H. Kawasaki,
Y. Hiasa,
K. Michitaka
|
6 |
2017 |
6
🐜
|
|
🐜
|
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review
12 auth.
Hiroyuki Fujii,
T. Tsuji,
T. Yuba,
Shunya Tanaka,
Yoshifumi Suga,
A. Matsuyama,
...
Ayaka Omura,
S. Shiotsu,
Chieko Takumi,
Seiko Ono,
Masahito Horiguchi,
Noriya Hiraoka
|
6 |
2020 |
6
🐜
|
|
🐜
|
Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease
20 auth.
A. Hiraoka,
K. Michitaka,
Hidetaro Ueki,
Miho Kaneto,
Toshihiko Aibiki,
Tomonari Okudaira,
Takamasa Kawakami,
H. Yamago,
Yoshifumi Suga,
Hideomi Tomida,
...
Yuji Miyamoto,
Nobuaki Azemoto,
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
T. Ninomiya,
M. Hirooka,
M. Abe,
B. Matsuura,
Y. Hiasa
|
5 |
2016 |
5
🐜
|
|
🐜
|
Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
19 auth.
A. Hiraoka,
Yoshihiro Ishimaru,
H. Kawasaki,
Toshihiko Aibiki,
Tomonari Okudaira,
A. Toshimori,
Tomoe Kawamura,
H. Yamago,
Hiromasa Nakahara,
Yoshifumi Suga,
...
Nobuaki Azemoto,
H. Miyata,
Y. Miyamoto,
T. Ninomiya,
M. Hirooka,
M. Abe,
B. Matsuura,
Y. Hiasa,
K. Michitaka
|
5 |
2015 |
5
🐜
|
|
🐜
|
Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy.
20 auth.
A. Hiraoka,
Tomoe Kawamura,
Toshihiko Aibiki,
Tomonari Okudaira,
A. Toshimori,
H. Yamago,
Hiromasa Nakahara,
Yoshifumi Suga,
Nobuaki Azemoto,
H. Miyata,
...
Y. Miyamoto,
T. Ninomiya,
T. Murakami,
Yoshihiro Ishimaru,
H. Kawasaki,
M. Hirooka,
M. Abe,
B. Matsuura,
Y. Hiasa,
K. Michitaka
|
4 |
2015 |
4
🐜
|
|
🐜
|
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
30 auth.
Satomi Tanaka,
J. Uchino,
T. Yokoi,
T. Kijima,
Yasuhiro Goto,
Yoshifumi Suga,
Yuki Katayama,
R. Nakamura,
K. Morimoto,
Akira Nakao,
M. Hibino,
Nozomi Tani,
T. Takeda,
H. Yamaguchi,
Yusuke Tachibana,
...
Chieko Takumi,
Noriya Hiraoka,
M. Takeshita,
Keisuke Onoi,
Y. Chihara,
Ryusuke Taniguchi,
Takahiro Yamada,
Y. Matsui,
Osamu Hiranuma,
Yoshie Morimoto,
M. Iwasaku,
Shinsaku Tokuda,
Y. Kaneko,
Tadaaki Yamada,
K. Takayama
|
4 |
2022 |
4
🐜
|
